The Gut-Skin Axis: What the Butyrate and SCFA Evidence Shows

The gut-skin axis#

Eczema has the strongest evidence: multiple randomized trials from 2023-2024 report probiotics reducing SCORAD scores, with SCFA levels tracking symptom improvement. Rosacea has the most surprising gut link: markedly higher rates of small intestinal bacterial overgrowth, and treating it often improves the skin. Acne and psoriasis rest on associations and mechanism, weaker so far. The common thread is the gut-skin axis, and specifically its metabolite layer.

Gut bacteria ferment dietary fibre into short-chain fatty acids, above all butyrate. Butyrate circulates in the blood and acts on inflammation and barrier function in skin: it suppresses NF-κB signalling, promotes regulatory T cells, and inhibits histone deacetylases. Most of that chain is cell and animal work. The human trials test the ends of it, not the whole pipeline, and the grading below keeps the two apart.

How the gut reaches the skin#

The newer work moves past the leaky-gut framing to microbial metabolites: biochemical messengers that travel through the bloodstream and act on skin cells directly.

The pathways:

Immune modulation#

About 70 percent of the body's immune cells sit in gut-associated tissue. Gut bacteria interact with immune receptors (TLRs, AHR, vitamin D receptor) to regulate systemic immune responses. When dysbiosis occurs, it promotes pro-inflammatory cytokines: IL-6, TNF-α, IL-17. These directly drive skin inflammation in conditions like psoriasis, atopic dermatitis, and acne.

Short-chain fatty acids#

The metabolite layer is the recent advance. Gut bacteria produce SCFAs, particularly butyrate, propionate, and acetate, when they ferment dietary fibre. These compounds:

• Enter your bloodstream and circulate systemically to your skin
• Suppress NF-κB signalling (reducing inflammatory cytokines)
• Promote regulatory T-cell differentiation (immune tolerance)
• Enhance both intestinal AND skin barrier integrity
• Inhibit histone deacetylases (epigenetic anti-inflammatory effects)

Butyrate is the best-studied of the three. 2024 work shows it suppressing Th17 inflammation (the psoriasis pathway), reducing Th2 responses (the eczema pathway), and modulating oxidative-stress pathways (NRF2 activation) in models. When dysbiosis cuts butyrate production, that anti-inflammatory signal drops.

Intestinal Barrier Dysfunction#

Dysbiosis reduces tight junction proteins (claudin, occludin), increasing intestinal permeability. Microbial products like lipopolysaccharide (LPS) enter circulation, triggering systemic inflammation that manifests as skin inflammation. Elevated LPS shows up consistently in people with inflammatory skin conditions.

Neuroendocrine Signaling (Gut-Brain-Skin Axis)#

Gut microbiota influence neuropeptides, stress hormones (cortisol), and vagal signaling. These signals alter skin barrier function, sebum production, and inflammatory responses. The proposed sequence runs from stress through dysbiosis and increased permeability to skin flare.

Oxidative Stress Regulation#

The gut microbiome regulates ROS (reactive oxygen species) and antioxidant pathways through AHR and NRF2 signalling, which influences how skin responds to UV, pollution, and ageing. Environmental stressors hit both gut and skin microbiomes simultaneously.

Leaky gut and skin inflammation#

The proposed bridge is increased intestinal permeability, working through several specific pathways:

LPS Translocation#

Lipopolysaccharide from gram-negative bacteria escapes through a leaky gut, triggering inflammatory cascades that manifest as skin inflammation. This activates the exact cytokines involved in acne formation and psoriatic plaques.

Molecular Mimicry#

Some gut bacteria produce proteins that resemble your own tissues. When these escape through a leaky gut, your immune system develops antibodies that can cross-react with skin proteins. This mechanism is well-documented in autoimmune skin conditions.

SCFA deficiency#

Dysbiosis reduces butyrate-producing bacteria (Faecalibacterium prausnitzii, Roseburia spp.). The documented losses:

• Tight junction support (worsening leaky gut)
• Anti-inflammatory signalling (increasing skin inflammation)
• Regulatory T-cell promotion (immune dysregulation)
• Skin barrier enhancement (impaired healing)

Bile Acid Metabolism#

Gut bacteria transform primary bile acids into secondary forms that act as signalling molecules. Dysbiosis disrupts this, affecting FXR and TGR5 receptors that regulate inflammation and metabolism systemically.

Condition by condition#

Acne#

Hormones matter, and Cutibacterium acnes plays a role. The gut evidence adds another input:

Gut Dysbiosis Patterns: People with acne consistently show different gut microbiome compositions: specifically reduced diversity and imbalances in beneficial taxa. Lower levels of SCFA-producing bacteria correlate with more severe acne.

LPS-Driven Inflammation: Circulating LPS from leaky gut triggers IL-6, TNF-α, and IL-1β. These are the inflammatory pathways involved in acne formation.

Butyrate Research: 2024 studies show that butyrate reduces inflammatory signalling triggered by C. acnes and decreases oxidative stress in sebaceous glands. Lower gut butyrate levels are associated with more severe acne, and restoring SCFA-producing bacteria correlates with improvement.

Insulin and IGF-1: Gut dysbiosis affects insulin signalling, which increases sebum production and skin cell turnover. Both are recognised acne drivers.

Eczema#

The gut-eczema link has the strongest clinical evidence in this set:

SCFA Deficiency Patterns: People with atopic dermatitis consistently show reduced SCFA levels. Multiple studies link this deficiency to impaired skin barrier and Th2-driven inflammation.

Clinical Trial Evidence (2023-2024): Multiple RCTs show:

• Probiotics (especially Lactobacillus rhamnosus GG and multi-strain formulations) can reduce SCORAD (eczema severity scores)
• Increased SCFA production correlates with improved itching and flare frequency
• Butyrate specifically improves skin barrier function and reduces Th2 inflammation

Early Microbiome Matters: Research shows gut microbiome composition in infancy predicts eczema risk. C-section births, early antibiotics, and lack of breastfeeding alter microbiome development in ways that increase atopic risk, partly through reduced SCFA production.

Mechanism: Butyrate promotes regulatory T-cell differentiation (immune tolerance) while suppressing Th2 responses (allergic inflammation). The proposed explanation for why SCFA restoration helps eczema specifically.

Psoriasis#

Psoriasis is classified as a systemic inflammatory disease, and the gut connection runs through the Th17 pathway:

Th17 Pathway Modulation: Butyrate suppresses IL-17 and IL-23 signalling. These are the core inflammatory drivers in psoriasis. It reduces keratinocyte hyperproliferation through epigenetic mechanisms (HDAC inhibition).

Microbiome Signatures: People with psoriasis show characteristic changes in gut bacteria composition, including reduced beneficial taxa and increases in pro-inflammatory species. Lower abundance of butyrate-producing bacteria correlates with disease severity.

Clinical Evidence: 2023-2024 trials report modest reductions in PASI scores with probiotic supplementation, along with improvement in inflammatory biomarkers. The mechanism appears to run from microbiome reshaping to increased SCFAs to reduced Th17 inflammation.

LPS Connection: Leaky gut allows LPS into circulation, driving the chronic inflammatory state that fuels psoriatic plaques. Butyrate helps seal the gut barrier, reducing LPS translocation.

Rosacea#

Rosacea has some of the strongest gut connections in the set:

SIBO Association: Studies find significantly higher rates of small intestinal bacterial overgrowth in people with rosacea. Treating SIBO often improves skin symptoms.

H. pylori Connection: This stomach bacterium is more prevalent in rosacea patients, and treating H. pylori often improves skin symptoms.

Trigger foods: The foods that commonly trigger rosacea flares (alcohol, spicy foods, histamine-rich foods) are also the ones that disrupt gut barrier function or feed problematic bacteria.

Video resources#

• Dr. Mark Hyman - The Gut-Skin Connection - Functional medicine perspective on treating skin conditions through gut healing
• Dr. Rupy Aujla - The Doctor's Kitchen - Evidence-based approach to acne and gut health
• Microbiome Explained - YouTube Search - Find latest videos on how gut bacteria affect your skin

Tip: Search YouTube for "gut skin axis", "butyrate benefits", or "microbiome acne" for the most recent educational content.

Practical protocol#

The protocol below works from the mechanisms discussed above.

On the doses below: the supplement amounts and serving targets here are general ranges from the nutrition and supplement literature, not doses from clinical trials of gut-skin protocols, and no trial has tested this sequence as a whole. The Research Sources section of this article covers mechanisms, not these figures. Treat them as descriptive, and work with a healthcare provider before acting on any of them.

Beginner: foundation#

Diet Shifts That Increase SCFAs:

• Eat diverse fibre daily (30g+): onions, garlic, leeks, asparagus, slightly green bananas, oats. All feed butyrate-producing bacteria
• Include resistant starch: cooled potatoes, rice, legumes. Particularly good for butyrate production
• Remove obvious gut irritants: processed sugar, industrial seed oils, excessive alcohol
• Fermented foods daily: kefir, sauerkraut, kimchi (start small if sensitive)

Daily Gut Support:

• Bone broth or collagen peptides (2-5g glycine/glutamine for gut lining repair)
• Prebiotic foods (the fibre mentioned above)
• Consider a quality multi-strain probiotic with Lactobacillus and Bifidobacterium species

This feeds the bacteria that produce butyrate and other SCFAs, the metabolites the sections above describe.

Intermediate: targeted support#

For Leaky Gut and SCFA Production:

• L-glutamine: 2-5g daily on empty stomach (fuels gut lining cells)
• Zinc carnosine: 75mg daily (supports mucosal repair and modulates immunity)
• Butyrate supplement: 300-600mg sodium or calcium butyrate (direct SCFA support)
• Colostrum: 1-2g daily (growth factors for gut lining repair)

For Microbial Balance:

• Consider targeted antimicrobials if SIBO suspected. Work with practitioner
• Rotate probiotic strains to avoid overgrowth of single species
• Support stomach acid: betaine HCl with meals if low (proper acid kills pathogens)

For Skin-Specific Support:

• Omega-3 fatty acids: 2-3g daily EPA/DHA (powerful anti-inflammatory)
• Zinc: 15-30mg daily (critical for skin healing and hormone balance)
• Vitamin D: optimise levels (most with skin conditions deficient)
• Quercetin: 500mg daily (mast cell stabiliser, reduces histamine)

The intent is barrier repair, SCFA production, and raw-material supply. None of it is trial-tested as a package.

Advanced: the full framework#

The 5 R framework:

1. Remove: Eliminate gut irritants, pathogens, inflammatory foods for 4-6 weeks
2. Replace: Add digestive support (enzymes, acids, bile) as needed
3. Reinoculate: Multi-strain probiotics (50-100 billion CFU), prebiotic fibres, fermented foods
4. Repair: L-glutamine, zinc carnosine, collagen, butyrate, bone broth
5. Rebalance: Stress management, sleep optimisation, nervous system regulation

SCFA Optimisation Protocol:

• Resistant starch supplement: 10-20g daily (start low, slow increase)
• Inulin supplement: 5-10g daily (prebiotic fibre)
• Diverse fibre intake: 30-50g daily from varied plant sources
• Consider tributyrin (butyrate precursor) if not responding to plain butyrate

Addressing the skin microbiome:

• Stop over-cleansing: protect the skin microbiome rather than stripping it
• Use pH-balanced products: acidic skincare (4.5-5.5) supports beneficial skin bacteria
• Consider microbiome-friendly skincare: products with prebiotics or probiotic lysates
• Be cautious with antibiotics: they decimate both gut and skin microbiomes

Liver support:

The liver filters blood from the gut before it reaches the skin. Support with:

• Bitters, cruciferous vegetables, adequate protein
• Consider binders if high toxic burden: activated charcoal, bentonite clay

The mind-skin connection: stress, cortisol, and flares#

Stress runs through every pathway above, through the gut-brain-skin axis:

• Cortisol increases intestinal permeability within hours
• Sympathetic dominance slows digestion
• Stress compounds impair skin barrier function
• Stress alters gut bacterial composition, reducing beneficial taxa

Practical stress management:

• Vagus nerve stimulation: humming, cold exposure, deep breathing (5-10 minutes daily)
• Movement you actually enjoy (not punishment exercise)
• Sleep optimisation: skin repair happens during deep sleep (7-9 hours)
• Mindfulness practices: even 5 minutes daily shifts your nervous system

What the 2023-2025 work adds#

• Butyrate acts through HDAC inhibition: epigenetic reprogramming of immune cells in models, an anti-inflammatory effect proposed to outlast the molecule itself
• SCFAs circulate systemically: they reach skin and act on keratinocytes and immune cells (model evidence)
• Probiotics work differently for each condition: strongest evidence for eczema, moderate for acne, emerging for psoriasis. Strain selection matters
• The gut-brain-skin axis: vagal signalling and cortisol effects on permeability make stress a main modifier, not a minor one
• Environment hits both microbiomes: UV, pollution, and chemicals affect gut and skin together; supporting the gut microbiome is the proposed way to help skin withstand them

Research Sources: 2023-2024 Studies on Butyrate and Skin Health#

Representative studies behind the claims above:

1. Butyrate, Inflammation, and Immune Regulation#

• Butyrate suppresses pro-inflammatory cytokines (TNF-α, IL-6, IL-17) and promotes regulatory T cells (Tregs) [PMID: 39137625]
• SCFAs regulate T-cell differentiation via HDAC inhibition and epigenetic mechanisms [PMID: 38623584]

2. Butyrate and Barrier Function (Gut and Skin)#

• Butyrate increases tight junction proteins (claudin, occludin) and improves barrier integrity [ScienceDirect]
• Dysbiosis reduces butyrate which increases inflammation and barrier dysfunction [Taylor & Francis]

3. Butyrate in Acne and Sebaceous Inflammation#

• SCFAs reduce inflammation triggered by Cutibacterium acnes and oxidative stress [PMID: 39137625]
• Lower SCFA levels associated with increased acne severity [PMID: 38623584]

4. Butyrate in Atopic Dermatitis (Eczema) - Strongest Evidence#

• Reduced SCFA levels observed in eczema patients, impacts barrier and inflammation [PMID: 38623584]
• Clinical trials show probiotics and SCFA production improve SCORAD and symptoms [ScienceDirect]

5. Butyrate in Psoriasis#

• Butyrate suppresses IL-17 and IL-23 (Th17 pathway) and reduces inflammation [PMID: 39137625]
• Lower butyrate-producing bacteria linked to psoriasis severity [ScienceDirect]

6. Epigenetic and Cellular Mechanisms#

• Butyrate acts as a histone deacetylase (HDAC) inhibitor creating anti-inflammatory gene regulation [PMID: 38623584]
• Reduces oxidative stress and supports skin repair mechanisms [ScienceDirect]

7. Gut-Skin Axis Mechanisms (Integrated Model)#

• Immune modulation, microbial metabolites, barrier integrity, and neuroendocrine signalling [Taylor & Francis]

Where this leaves the evidence#

The pathway biology is in good shape; what the trials test is whether acting on the gut changes the skin, and there the effects are modest so far. The metabolite layer, SCFAs and butyrate, is the strongest part of the story: preclinical mechanism, eczema trials at the top of the human evidence, psoriasis at the bottom, and a protocol section no study has tested as a sequence. Patience is a practical requirement either way.